The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "psoriasis"

Search results for: psoriasis

Guselkumab May Best Adalimumab for Psoriasis on the Scalp, Palms & Soles

May 29, 2018 • By Marilynn Larkin

NEW YORK (Reuters Health)—The interleukin 23 inhibitor guselkumab is associated with more improvement in psoriasis on the scalp, palms and/or soles compared with adalimumab, a new analysis suggests. Andrew Blauvelt, MD, MBA, of Oregon Medical Research Center in Portland conducted a secondary analysis of data from the international VOYAGE 1 and VOYAGE 2 studies, double-blind,… [Read More]

Filed Under: Biologics & Biosimilars, Drug Updates Tagged With: adalimumab, feet, guselkumab, hand, Psoriasis, scalp

Risankizumab Promising for Psoriasis; Plus Canada Approves Brodalumab

March 21, 2018 • By Michele B. Kaufman, PharmD, BCGP

Two Phase 3 clinical trials show that risankizumab is effective for achieving skin clearance in patients with psoriasis…... [Read More]

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: brodalumab, Canada, plaque psoriasis, Psoriasis, risankizumab, ustekinumab

Ixekizumab Promising for AS; Plus Certolizumab Pegol Studied for Psoriasis

March 14, 2018 • By Michele B. Kaufman, PharmD, BCGP

In a Phase 3 study, ixekizumab proved safe and effective to treat adults with ankylosing spondylitis (AS)…... [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates, Spondyloarthritis Tagged With: Ankylosing Spondylitis, Certolizumab Pegol, ixekizumab, Psoriasis

Secukinumab Promising for Sustained Improvements in Palmoplantar & Nail Psoriasis

February 28, 2018 • By Michele B. Kaufman, PharmD, BCGP

In clinical trials, secukinumab proved safe and effective as a long-term treatment for both palmoplantar and nail psoriasis…... [Read More]

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: nail psoriasis, nails, palmoplantar psoriasis, Psoriasis, secukinumab

Psoriasis Tied to Higher Risk of Serious Liver Disease

November 13, 2017 • By Lisa Rapaport

(Reuters Health)—People with chronic inflammatory disorders, such as psoriasis and rheumatoid arthritis (RA), may have an increased risk of developing serious liver damage, a recent study suggests. These inflammatory disorders are often treated with methotrexate, a medication linked to an increased risk of liver disease. For the current study, researchers followed more than 1 million… [Read More]

Filed Under: Conditions, DMARDs & Immunosuppressives, Drug Updates, Rheumatoid Arthritis Tagged With: liver, liver disease, metho­trexate, Psoriasis, Rheumatoid Arthritis (RA), skin

Rheumatology Drug Updates: Efficacy Studied Following Accelerated Drug Approvals; Plus Secukinumab Meets Benchmark for Psoriasis

November 9, 2017 • By Michele B. Kaufman, PharmD, BCGP

Medications for serious or life-threatening conditions may receive accelerated approval from the U.S. Food and Drug Administration (FDA) by showing an effect on surrogate measures that are reasonably likely to predict a treatment’s clinical benefit. Post-approval confirmatory drug trials are then required to determine whether or not these effects translate into clinical improvements. In recent… [Read More]

Filed Under: Conditions, DMARDs & Immunosuppressives, Drug Updates, Spondyloarthritis Tagged With: accelerated approval, Ankylosing Spondylitis, Clinical, drug, efficacy, FDA, Medication, outcome, Psoriasis, psoriatic arthritis, Research, rheumatology, Safety, secukinumab, study, Treatment, trial

Ustekinumab Approved for Use in Adolescents with Plaque Psoriasis

November 3, 2017 • By Michele B. Kaufman, PharmD, BCGP

In October, the FDA approved ustekinumab to treat patients 12 years or older who have moderate to severe plaque psoriasis…... [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates Tagged With: adolescent, FDA, plaque psoriasis, Psoriasis, U.S. Food and Drug Administration (FDA), ustekinumab

Secukinumab Meets 5-Year Benchmark for Psoriasis

October 6, 2017 • By Michele B. Kaufman, PharmD, BCGP

In an extension study, nearly half the patients with plaque psoriasis taking secukinumab maintained skin clearance for the five years of the study…... [Read More]

Filed Under: Biologics & Biosimilars, Spondyloarthritis Tagged With: Ankylosing Spondylitis, Psoriasis, psoriatic arthritis, secukinumab

Beyond Awareness: August Is Psoriasis Action Month

August 15, 2017 • By Richard Quinn

This month, the National Psoriasis Foundation is urging patients and rheumatologists to take charge of psoriatic disease by setting ambitious treatment goals to achieve better health outcomes…... [Read More]

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Awareness, National Psoriasis Foundation, Psoratic Arthritis, Psoriasis, Psoriasis Action Month, public health

Molecular Differences Between Pediatric & Adult Psoriasis Plaques

July 10, 2017 • By Marilynn Larkin

NEW YORK (Reuters Health)—The pathology of pediatric psoriasis differs from that of adult psoriasis, a finding that has implications for treatment, researchers suggest. “Pediatric psoriasis often differs from adult psoriasis in presentation, triggers, natural history, and response to therapy, suggesting potential differences in the pathophysiology of the disease processes,” Dr. Kelly Cordoro of the University… [Read More]

Filed Under: Conditions, Scleroderma Tagged With: adult, Children, Pediatric, plaque, Psoriasis, skin

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 43
  • Next Page »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.